All News about Novartis Ag ADR
![](https://cdn.benzinga.com/files/images/story/2024/Novartis.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Businessman-Markets-Shutterstock_2.jpeg?width=1200&height=800&fit=crop)
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
January 31, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
![](https://cdn.benzinga.com/files/images/story/2024/01/31/google_-logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Novartis
January 30, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Via Benzinga
Novartis AG (NYSE: NVS) Records 52-Week High Friday Morning
January 05, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Big Players' Recent Trades in NVS Options
January 04, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/08/healthcare_staffing1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Microsoft-and-Apple.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Gilead_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/cancer_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://cdn.pixabay.com/photo/2017/08/26/10/47/businessman-2682712__340.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/CYTK.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/11/Stock-bounce-05-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/11/cytk.png?width=1200&height=800&fit=crop)
![](https://images.pexels.com/photos/187041/pexels-photo-187041.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://cdn.benzinga.com/files/images/story/2024/01/09/medications-257336_12805.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/08/cytk_co.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-Cytokinetics-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/08/exel_co.png?width=1200&height=800&fit=crop)
Insufficient self-sufficiency of raw materials in Japan
January 08, 2024
Via AB Newswire
Topics
Supply Chain
Exposures
Supply Chain
![](https://www.marketbeat.com/logos/articles/med_20240108080704_voyager-therapeutics-pops-30-on-gene-therapy-deal.jpg)
![](https://www.investors.com/wp-content/uploads/2023/05/Stock-merckhq-rahway-03-company.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240108072132_2-low-priced-gene-therapy-stocks-to-speculate-on.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/08/isomorphic.png?width=1200&height=800&fit=crop)
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://www.investors.com/wp-content/uploads/2023/01/Stock-AIbiotech-01-adobe.jpg)
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.